Compound guide
A pathway-focused guide to molecular mechanisms, published evidence, and the limits of interpretation.
Overview
ARA-290, also called cibinetide, is an 11-amino-acid peptide modeled on part of erythropoietin. It is studied in cellular injury and small-nerve-fiber research.
A proposed innate repair receptor model involves EPOR and CD131. Reported downstream observations include inflammatory, oxidative-stress and cell-death markers; a broad therapeutic mechanism is not established here.
The 2012 randomized pilot enrolled 22 participants with sarcoidosis-associated symptoms. Other small studies measured nerve-fiber and metabolic endpoints. Their investigational formulations, selected populations and short observation periods limit interpretation; they do not validate this catalog vial.
Research model
These receptors, enzymes, and signaling networks define the primary laboratory questions associated with this research material.
The literature describes an innate repair receptor distinct from the erythropoietin receptor system associated with red-cell production. EPOR/CD131 involvement is a proposed framework, not proof of every reported tissue effect.
A cisplatin injury study in HEK-293 and ACHN cells measured reactive oxygen species, cytokines and apoptosis-related markers after exposure to ARA-290.
Small studies in sarcoidosis or diabetes examined symptom questionnaires and corneal nerve-fiber measurements. Some endpoints changed, but the studies do not establish broad efficacy or long-term safety.
Map the research pathway
Follow each target through its intracellular signal, the model being observed, and the evidence boundary that governs interpretation.
The literature describes an innate repair receptor distinct from the erythropoietin receptor system associated with red-cell production.
Receptor-context experiments are needed to distinguish a pathway hypothesis from direct target engagement.
Pathway activity does not establish safety, efficacy, or suitability for personal use.
A cisplatin injury study in HEK-293 and ACHN cells measured reactive oxygen species, cytokines and apoptosis-related markers after exposure to ARA-290.
ROS, TNF-alpha/IL-6, caspase-3 and Bax/Bcl-2 readouts; these are model-specific markers, not patient outcomes.
Pathway activity does not establish safety, efficacy, or suitability for personal use.
Small studies in sarcoidosis or diabetes examined symptom questionnaires and corneal nerve-fiber measurements.
Symptom scores, corneal nerve-fiber density and selected metabolic measures; interpret each study population and comparator separately.
Pathway activity does not establish safety, efficacy, or suitability for personal use.
Pathways examined together
Research interpretation
The research asks whether part of a hormone’s signaling can be separated from its other actions.
These assays track how cells respond to a defined experimental stressor.
A change in a symptom score and a change in nerve imaging are different observations.
The 2012 randomized pilot enrolled 22 participants with sarcoidosis-associated symptoms. Other small studies measured nerve-fiber and metabolic endpoints. Their investigational formulations, selected populations and short observation periods limit interpretation; they do not validate this catalog vial.
Read the evidence
Continue exploring
More compounds organized within the cellular response research area.
This research blend pairs BPC-157, a synthetic 15-amino-acid peptide, with a thymosin beta-4 reference commonly labeled TB-500.
Open compound guide ↗
GLOW BLEND is a fixed research mixture containing nominal amounts of BPC-157, GHK-Cu, and a TB-500 reference associated with thymosin beta-4 biology.
Open compound guide ↗
GHK-Cu is a copper complex of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine.
Open compound guide ↗One important note
The 2012 randomized pilot enrolled 22 participants with sarcoidosis-associated symptoms. Other small studies measured nerve-fiber and metabolic endpoints. Their investigational formulations, selected populations and short observation periods limit interpretation; they do not validate this catalog vial.
This guide summarizes molecular mechanisms, published evidence, and evidence limits in everyday language. It is educational information, not medical advice or instructions for personal use. Products offered on this site are intended exclusively for laboratory research and are not for human or veterinary use.
